The FIRST PETT randomised control trial is open for recruitment. If you are interested in taking part or finding out more about what taking part involves, please have a read through our website. If you have questions, please contact the research team on firstpett@kcl.ac.uk, or, if you are interested in applying to take part, please follow the link below:

The PTSD Experimental Treatment Trial (FIRST PETT) involves undertaking a novel, effective PTSD treatment called Fast Imagery Reversal Script for Trauma-release (FIRST).

FIRST is a possible new treatment for PTSD. It uses a process where the person is asked to visualise in a way that is intended to be comfortable, non-traumatising, and non-intrusive. We are aiming to recruit 215 UK military veterans to participate, who will be randomly allocated to receive either a) the FIRST treatment immediately, or b) to be placed on a waiting list to receive the FIRST treatment after twenty four weeks. We want to find out if FIRST therapy is effective in reducing PTSD symptoms, how it works and whether it can be recommended as a standard NHS treatment option in the future.

Partners involved

This project (NIHR153865) is funded by the Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership. The views expressed in this publication are those of the author(s) and not necessarily those of the MRC, NIHR or the Department of Health and Social Care.

This study has been funded by the Forces in Mind Trust (FiMT), a £35 million funding scheme run by the FiMT using an endowment awarded by The National Lottery Community Fund.